Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Regulus Therapeutics Inc.

    NASDAQ: RGLS · Real-Time Price · USD
    8.16
    0.00 (0.00%)
    At close: Jun 24, 2025, 3:59 PM

    Regulus Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 21.15M 122K 459K
    Gross Profit
    		 n/a -21.15M -122K -459K
    Operating Income
    		 -50.04M -31.11M -28.24M -27.82M
    Interest Income
    		 3.84M 1.68M 605K 864K
    Pretax Income
    		 -46.36M -30.04M -28.32M -27.81M
    Net Income
    		 -46.36M -30.04M -28.32M -27.81M
    Selling & General & Admin
    		 14.67M 9.96M 9.83M 10.02M
    Research & Development
    		 35.37M 21.01M 18.41M 17.79M
    Other Expenses
    		 n/a -21.01M -83K 9K
    Operating Expenses
    		 50.04M 9.96M 28.24M 27.82M
    Interest Expense
    		 158K 604K 688K 855K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 50.04M 31.11M 28.24M 27.82M
    Income Tax Expense
    		 1K 1K 1K 1K
    Shares Outstanding (Basic)
    		 56.35M 18.96M 15.26M 8.57M
    Shares Outstanding (Diluted)
    		 56.35M 18.96M 15.26M 8.57M
    EPS (Basic)
    		 -0.82 -1.58 -1.86 -3.24
    EPS (Diluted)
    		 -0.82 -1.58 -1.86 -3.24
    EBITDA
    		 -45.85M -30.88M -28.12M -27.36M
    EBIT
    		 -46.2M -31.11M -28.24M -27.82M
    Depreciation & Amortization
    		 347K 227K 122K 459K

    Add to Watchlist